Our company has established the industry's most clinically advanced hUC-MSC product candidates based on our extensive R&D experiences in the development of hUC-MSC therapeutics over the past two decades.  We are dedicated to using hUC-MSC technologies to address the unmet medical needs in multiple difficult-to-treat diseases.

​​